The R&D World Index (RDWI) for the week ending January 7, 2022, closed at 5,472.25 for the 25 companies in the RDWI. The Index was down -2.79% (or -157.25 basis points) from the week ending December 31, 2021. The stock of 16 RDWI members gained value from 0.17% (Roche Holdings AG) to 17.67% (Ford Motor).…
EVs becoming more collaborative, in this week’s R&D power Index
The R&D World Index (RDWI) for the week ending December 31, 2021, closed at 5,629.50 for the 25 companies in the RDWI. The Index was down -0.39% (or -22.32 basis points) from the week ending December 24, 2021. The stock of 21 RDWI members gained value from 0.11% (Alibaba) to 3.02% (General Motors). The stock…
Most new COVID-19 U.S. cases are Omicron variants, in this week’s R&D Power Index
The R&D World Index (RDWI) for the week ending December 24, 2021, closed at 5,651.82 for the 25 companies in the RDWI. The Index was up 2.42% (or 133.72 basis points) from the week ending December 17, 2021. The stock of 20 RDWI members gained value from 0.01% (Johnson & Johnson) to 3.66% (Alphabet/Google). The…
Positive results for Pfizer’s COVID-19 pill, this week in the R&D Power Index
The R&D World Index (RDWI) for the week ending December 17, 2021, closed at 5,518.10 for the 25 companies in the RDWI. The Index was down -2.09% (or -117.84 basis points) from the week ending December 10, 2021. The stock of 14 RDWI members gained value from 0.06% (Intel) to 12.69% (Pfizer). The stock of…
Samsung reorganizes and EPA relents on regs, this week in the R&D Power Index
The R&D World Index (RDWI) for the week ending December 10, 2021, closed at 5,635.94 for the 25 companies in the RDWI. The Index was up 4.19% (or 226.57 basis points) from the week ending December 3, 2021. The stock of 19 RDWI members gained value from 0.07% (Bristol-Myers Squibb) to 16.31% (Oracle). The stock…
Biopharms scambling to find Omicron variant drug, this week in the R&D Power Index
The R&D World Index (RDWI) for the week ending December 3, 2021, closed at 5,409.37 for the 25 companies in the RDWI. The Index was down -1.28% (or -70.04 basis points) from the week ending November 26, 2021. The stock of 11 RDWI members gained value from 0.11% (Johnson & Johnson) to 3.21% (Apple). The…
Omicron variant to take weeks to evaluate, this week in the R&D Power Index
The R&D World Index (RDWI) for the week ending November 26, 2021, closed at 5,479.41 for the 25 companies in the RDWI. The Index was down -3.48% (or -197.51 basis points) from the week ending November 19, 2021. The stock of four RDWI members gained value from 0.23% (AbbVie) to 6.30% (Pfizer). The stock of…
Ford and GM to develop their own chips, in this week’s R&D Power Index
The R&D World Index (RDWI) for the week ending November 19, 2021, closed at 5,676.92 for the 25 companies in the RDWI. The Index was down -0.30% (or -17.12 basis points) from the week ending November 12, 2021. The stock of nine RDWI members gained value from 0.17% (Alphabet/Google) to 7.04% (Apple). The stock of…
Mega companies splitting their R&D bases, in this week’s R&D Power Index
The R&D World Index (RDWI) for the week ending November 12, 2021, closed at 5,694.04 for the 25 companies in the RDWI. The Index was down -0.05% (or -2.90 basis points) from the week ending November 5, 2021. The stock of eight RDWI members gained value from 0.20% (Microsoft) to 8.34% (General Motors). The stock…
Large R&D firms are restructuring, this week in the R&D Power Index
San Diego becoming larger life science hub, in this week’s R&D Power Index
Even more EV batteries to be built, in this week’s R&D Power Index
The R&D World Index (RDWI) for the week ending October 22, 2021, closed at 5,391.27 for the 25 companies in the R&D World Index. The Index was down -1.19% (or -65.00 basis points) from the week ending October 15, 2021. The stock of 12 R&D World Index members gained value from 0.1.50% (Johnson & Johnson)…
Economic and R&D growth slowing in 2022, in this week’s R&D Power Index
Billions being invested in new battery R&D, in this week’s R&D Power Index
GM fixing all Chevy Bolts, in this week’s R&D Power Index
The R&D World Index (RDWI) for the week ending September 24, 2021, closed at 5,443.09 for the 25 companies in the R&D World Index. The Index was up 0.34% (or 18.55 basis points) from the week ending September 17, 2021. The stock of 12 R&D World Index members gained value from 0.11% (Pfizer) to 8.62%…
Researchers work to clear up COVID-19 booster confusion, in this week’s R&D Power Index
The R&D World Index (RDWI) for the week ending September 17, 2021, closed at 5,424.54 for the 25 companies in the R&D World Index. The Index was down -0.71% (or -38.62 basis points) from the week ending September 10, 2021. The stock of nine R&D World Index members gained value from 0.78% (Intel) to 6.86%…
Politics and the pandemic cut into global R&D spending, this week in the R&D Power Index
The R&D World Index (RDWI) for the week ending September 10, 2021, closed at 5,463.16 for the 25 companies in the R&D World Index. The Index was down -2.39% (or -133.49 basis points) from the week ending September 3, 2021. The stock of four R&D World Index members gained value from 0.03% (Honda) to 1.37%…
Carnegie Mellon University to build automated lab, this week in the R&D World Index report
Chip makers continue to expand their businesses, in the R&D World Index this week
Automotive chip shortage changing strategies, in this week’s R&D World Index
The R&D World Index (RDWI) for the week ending August 20, 2021, closed at 5,448.97 for the 25 companies in the R&D World Index. The Index was down -0.97% (or -35.07 basis points) from the week ending August 13, 2021. The stock of 11 R&D World Index members gained value from 0.26% (Roche Holdings) to…
